2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...
Meet Veristat at DIA Europe, March 18-20, 2025
Join us at DIA Europe 2025, the largest neutral life sciences conference in the region, where science, innovation, and regulatory experts converge.
Veristat is a global, science-driven CRO and consultancy dedicated to accelerating the development, approval, and commercialization of groundbreaking therapies. With flexible, scalable engagement models for clinical trial planning, execution, regulatory affairs and strategic consulting, we help Sponsors bring life-changing treatments to patients worldwide.
March 18-20, 2025, Congress Center Basel, Switzerland
DIA Europe is the largest neutral life sciences conference in the region, bringing together leaders from science, healthcare, patient advocacy, and regulatory sectors. Veristat experts will be on-site, ready to discuss how Veristat’s tailored solutions can help navigate the complexities of the European market and beyond.
Let’s connect. Schedule a meeting with Veristat today.
Veristat Attendees:
Beatrice Oberle-Rolle – VP Quality Assurance and Pharmacovigilance
Anja Bührer - VP Regulatory Affairs
Conference Details:
Date: March 18-20, 2025
Location: Congress Center Basel, Messeplatz 21, 4058 Basel, Switzerland
Schedule a Meeting:
Fill out the form to schedule a meeting with our experts and explore how Veristat can accelerate your clinical trials, regulatory submissions, and market access strategies toward success.
Learn more about the conference
5 min read
ASCO 2026: ADCs Are Redefining What Targeted Therapy Can Do
Jul 2, 2026 Veristat Blog
Antibody-drug conjugates — or ADCs — are not new. The concept of a "magic bullet" that delivers a cytotoxic payload...